The effect of liftfree mobilization on the pulmonary ability and quality of life among patients suffering from COPD level III-IV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004807

Enrollment

Registered

2013-03-12

Start date

2013-03-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9

Interventions

Group 1: In the course of their 4-weeks stay in hospital patients receive 10 treatments altogether (2-3 treatments per week with a treatment of 30 minutes each) including therapeutical treatment of li

Eligibility

Sex/Gender

All

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: Criterion for inclusion: COPD III-IV (GOLD); sex:m/w; none-smoker (for more than 6 months); age: 50-70 years; BMI: <30

Exclusion criteria

Exclusion criteria: Criterion for exclusion: maligne tumore; chemotherapy/radiation therapy for the previous 12 months; smoker; transplantation of lungs; acute excacerbation; acute fractures; psycho-logical disease; cardiac pacemaker; neurological disease.

Design outcomes

Primary

Measure	Time frame
Evaluation of pulmonary data: FEV 1 (forced expiratory volume), FEV 1% VC (vital capacity) and TLC (total lung capacity) via pulmonary diagnostics prior to the study and after having received 10 singular treatments.	—

Secondary

Measure	Time frame
Questions concerning the quality of life, collected prior to the study and after 4 weeks and after having received 10 singular treatments via questionnaire: EORTC QLQ-C 30	—

Countries

Germany

Contacts

Public ContactMarkus Oehl

Praxis für Physiotherapie

info@physio-oehl.de0261 / 1339150

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026